Matthias Pfisterer, University Hospital Basel American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 422-11. Lancet 2005:366:921 Clopidogrel therapy may
Matthias Pfisterer, University Hospital BaselAmerican College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta.Abstract Number: 422-11. Lancet 2005:366:921Clopidogrel therapy may need to be prolonged among patients treated with angioplasty plus drug eluting stent implantation as compared with those getting bare metal stents. That’s the outcome of the BASKET (Basel Stent Cost Effectiveness Trials) study announced at the American College of Cardiology conference in Atlanta. Sarah Maxwell heard results from Matthias Pfisterer from Basel.
Related Episodes
TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?
Gregg Stone REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GREGG STONE, Columbia University, New York New light has been thrown on the u
TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
Gordon Tomaselli Daniel Jones REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GORDON TOMASELLI, Johns Hopkins Universit
Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI
Laura Mauri Raymond Gibbons REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida LAURA MAURI, Brigham and Woman’s Hospit